Sign in
4

Changes in Ownership

Indaptus Therapeutics, Inc. Filed Acc 0001493152-25-029355

Co-Chief Executive Officer acquired 216,617 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Meckler Jeffrey A Co-Chief Executive Officer 2025-12-22 Grant or award +216,617 $2.03 $439,733 229,929 D
Loading xslF345X05/ownership.xml…